Neal Gerber & Eisenberg LLP
General
Cases213
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
Transport., E-Comm.Mech Eng, ManufCommunications
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/23/24 | SEALED MOTION To Dismiss Breach-Of-Contract Counterclaims by Fall Line Patents, LLC. (Attachments: # [1] Exhibit 1 [11/14/22 Agreement], # [2] Proposed Order)(Antonelli, Matthew) (Entered: 12/23/2024) | |
| 09/12/24 | NOTICE of Voluntary Dismissal by Pet Technology Worldwide, LLC, Spectrum Brands, Inc. Notice of Settlement and Dismissal Under Rule 41(A)(1) as to Defendant Nos. 22 And 96 (Manske, William) (Entered: 09/12/2024) | |
| 09/12/24 | MINUTE entry before the Honorable John J. Tharp, Jr: Upon receipt of the plaintiffs' notice of voluntary dismissal pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i) [180] , defendant nos. 25, 31, 35, and 36 are dismissed from this case. Mailed notice (air, ) (Entered: 09/12/2024) | |
| 09/12/24 | ORDER Signed by the Honorable John J. Tharp, Jr on 9/12/2024: For the reasons set forth in the Statement below, the emergency motion of defendant nos. 57-60 [168] is denied. (For further details see order) Mailed notice(air, ) (Entered: 09/12/2024) | |
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Dexcel and Aurobindo's First Set of Common Requests for the Production of Documents and Things (Nos. 1-7) filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 09/03/24 | NOTICE OF SERVICE of Plaintiffs' Supplemental Disclosure of Asserted Claims and Infringement Contentions for Zenara's ANDA Product filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., The Scripps Research Institute, Wyeth LLC.(Dellinger, Megan) (Entered: 09/03/2024) | |
| 08/09/24 | ORDER STAYING CASE. IT IS HEREBY ORDERED AND ADJUDGED that the parties' Motion is hereby GRANTED [Doc. 41], and this case is hereby STAYED for thirty (30) days until September 9, 2024. Signed by Magistrate Judge Debra C Poplin on 8/9/2024. (DCB) Mailed to Blake M Bernard Bradley, Arant, Boult, Cummings LLP 1221 Broadway Suite 2400 Nashville, TN 37203 (Entered: 08/09/2024) | |
| 07/10/24 | MINUTE entry before the Honorable LaShonda A. Hunt: Moving Defendants' Opposed Motion to Dismiss Plaintiff's Complaint 29 is taken under advisement. The Court adopts the parties' proposed briefing schedule: Plaintiff's response in opposition is due by 7/30/24, and Defendants' reply in support is due by 8/13/24. The Court will rule by mail. All proceedings are stayed pending further court order. No appearance is necessary on 7/16/24. Emailed notice. (cdh, ) (Entered: 07/10/2024) | |
| 07/02/24 | MINUTE entry before the Honorable Sara L. Ellis: Telephone conference held on 7/2/2024. The Court adopts the Defendants' proposed dates in the joint status report 103 . Evidentiary (Markman) Hearing set for 6/30/2025 at 10:00 AM. Telephone Conference set for 12/17/2024 at 9:30 AM with joint status report due by 12/12/2024. Mailed notice (rj, ) (Entered: 07/02/2024) | |
| 04/10/24 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Gland Pharma Limited on April 9, 2024, filed by Actelion Pharmaceuticals Ltd.. (Blumenfeld, Jack) (Entered: 04/10/2024) |